Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. (Q40479410)

20 September 2017

title

Cardiac and skeletal muscle involvement in myotonic dystrophy type 2 (DM2): a quantitative 31P-MRS and MRI study. (English)

1 reference

Christiane Schneider-Gold

20 September 2017

1 reference

object named as

Christiane Schneider-Gold

1

0 references

Herbert Köstler

object named as

Herbert Köstler

3

0 references

Klaus Viktor Toyka

7

object named as

Klaus V Toyka

1 reference

20 September 2017

Meinrad Beer

2

1 reference

20 September 2017

Stefan Buchner

4

1 reference

20 September 2017

Jörn Sandstede

5

1 reference

20 September 2017

Dietbert Hahn

6

1 reference

20 September 2017

publication date

1 November 2004

1 reference

20 September 2017

1 reference

20 September 2017

volume

30

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

636-644

1 reference

Skeletal muscle metabolism in myotonic dystrophy A 31P magnetic resonance spectroscopy study.

20 September 2017

cites work

1 reference

Cardiac metabolism and function in patients with multiple sclerosis: a combined 31P-MR-spectroscopy and MRI study.

21 January 2018

1 reference

Quantitative analysis of energy metabolism in human muscle using SLOOP 31P-MR-spectroscopy

21 January 2018

1 reference

Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy

21 January 2018

1 reference

MR spectroscopy of the human heart: the status and the challenges

21 January 2018

1 reference

Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

21 January 2018

1 reference

Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

21 January 2018

1 reference

Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum

21 January 2018

1 reference

Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.

21 January 2018

1 reference

Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9

21 January 2018

1 reference

Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy

21 January 2018

1 reference

Myotonic dystrophy and the heart

21 January 2018

1 reference

Myotonic dystrophy and proximal myotonic myophathy

21 January 2018

1 reference

Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging.

21 January 2018

1 reference

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes

21 January 2018

1 reference

Ageing: effects on oxidative function of skeletal muscle in vivo.

21 January 2018

1 reference

Use of magnetic resonance spectroscopy for in vivo evaluation of high-energy phosphate metabolism in normal and abnormal myocardium

21 January 2018

1 reference

Proximal myotonic myopathy: a syndrome with a favourable prognosis?

21 January 2018

1 reference

Report of the 84th ENMC Workshop: PROMM (Proximal Myotonic Myopathy) and Other Myotonic Dystrophy-Like Syndromes: 2nd Workshop. 13–15th October, 2000, Loosdrecht, The Netherlands

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MUS.20156

1 reference

20 September 2017

1 reference